GLP inspection for global drug development
نویسندگان
چکیده
منابع مشابه
A Global Software Inspection Process for Distributed Software Development
Globally distributed software development is an established trend towards delivering high-quality software to global users at lower costs. The main expected benefits from distributed software development are improvements in development time efficiency, being close to the customers and having flexible access to greater and less costly resources. Organizations require to use their existing resour...
متن کاملThe central GLP-1: implications for food and drug reward
Glucagon-like-peptide-1 (GLP-1) and its long acting analogs comprise a novel class of type 2 diabetes (T2D) treatment. What makes them unique among other T2D drugs is their concurrent ability to reduce food intake, a great benefit considering the frequent comorbidity of T2D and obesity. The precise neural site of action underlying this beneficial effect is vigorously researched. In accordance w...
متن کاملDevelopment of Inspection System for Wooden Chopsticks
Our aim is to development of the inspection system of wooden chopsticks, and in this paper, we develop the prototype for high-class disposable wooden chopsticks by computer vision technology. We propose a method of inspecting the four items of fine grain sample, coarse grain sample, unpeeled sample, and defective sample. Moreover, we addressed not only the proposal of the algorithm but developm...
متن کاملDevelopment of Inspection Robots for Bridge Cables
This paper presents the bridge cable inspection robot developed in Korea. Two types of the cable inspection robots were developed for cable-suspension bridges and cable-stayed bridge. The design of the robot system and performance of the NDT techniques associated with the cable inspection robot are discussed. A review on recent advances in emerging robot-based inspection technologies for bridge...
متن کاملFactors Affecting Drug‐Development Strategies in Asian Global Clinical Trials for Drug Approval in Japan
We assessed the current status of Asian global clinical trials (GCTs) and factors, such as therapeutic areas, main metabolic enzymes targeted, approval status in the United States or the European Union, development strategies, influencing drug-development strategies in Asian GCTs and in general GCTs for drug approval in Japan. The findings suggested that region-specific diseases in Asia, intrin...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Folia Pharmacologica Japonica
سال: 2007
ISSN: 0015-5691,1347-8397
DOI: 10.1254/fpj.130.408